Track topics on Twitter Track topics that are important to you
Mediaplanet’s Rare Diseases campaign found within USA TODAY and online highlights approved treatment options along with new investigational research and innovations in rare diseases.
NEW YORK (PRWEB) September 14, 2018
Today, Mediaplanet announces the launch of this September’s edition of “Rare Diseases." This campaign will showcase the innovative work being done within rare diseases research, diagnostics, and will highlight what industry experts and patients see as potential future therapies for those living with rare diseases.
Clay Matthews, Super Bowl-winning linebacker for the Green Packers, is the cover story of the print edition. Matthews is a long-term supporter of those who battle a rare disease, Duchenne, and he works closely with CureDuchenne to raise awareness for this disease that effects 15,000 American boys. Matthews hopes to inspire others with platforms like his to use their power to give back, and he hopes to build on his own progress that he’s already helped to create.
“When I joined forces with CureDuchenne, this was a relatively unknown disease” says Matthews. But we’re at the point now where there are human clinical trials, and the symptoms of this disease are being checked.”
Matthews has even started his own initiatives within the NFL — namely, the “My Cleats, My Cause” campaign, where he wore two cleats customize-made with submitted designs by boys with Duchenne. “They were loud, and that’s what I liked about them,” he says. “A lot of people were asking questions.”
Matthews hopes to inspire others with platforms like his to use their power to give back, and he hopes to build on his own progress that he’s already helped to create.
The print component of "Rare Diseases" is distributed within this weekend's edition of USA Today in New York, San Francisco, Los Angeles, Chicago, Boston, Seattle, Houston, with a circulation of approximately 250,000 copies and an estimated readership of 750,000. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, click here.
This campaign was made possible with the support of National Organization for Rare Disorders (NORD), BERG, NFL Green Bay Packer Clay Matthews, CureDuchenne, PTC Therapeutics, Boehringer Ingelheim, Incyte, Strongbridge Biopharma, Progenics Pharmaceuticals, Horizon Pharma, Cytokinetics, Retrophin, Centogene, Dante Labs, Global Genes, Rare Disease United Foundation, Chloe’s Fight Rare Disease Foundation, Rare & Undiagnosed Network, RUN’s NBA Initiative, and Cheyanna's Champions 4 Children.
Mediaplanet is the leading independent publisher of content marketing campaigns covering a variety of topics and industries such as Health, Education, Lifestyle, Business and Technology, and Corporate Social Responsibility. We turn consumer interest into action by providing readers with motivational editorial, pairing it with relevant advertisers and distributing it within top newspapers and online platforms around the world. Please visit http://www.mediaplanet.com for more on who we are and what we do.
For the original version on PRWeb visit: https://www.prweb.com/releases/mediaplanet_partners_up_with_nord_global_genes_clay_matthews_and_more_to_help_raise_awareness_for_rare_diseases/prweb15764435.htmNEXT ARTICLE
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...